Connection

Nicole Kuderer to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Nicole Kuderer has written about Treatment Outcome.
Nicole Kuderer
Connection Strength
0.062
Treatment Outcome
  1. Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma. Cancer Invest. 2021 Jul-Aug; 39(6-7):449-456.
    View in: PubMed
    Score: 0.034
  2. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer Discov. 2020 10; 10(10):1514-1527.
    View in: PubMed
    Score: 0.008
  3. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. N Engl J Med. 2019 02 21; 380(8):720-728.
    View in: PubMed
    Score: 0.007
  4. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial. Thromb Haemost. 2017 11 01; 117(11):2135-2145.
    View in: PubMed
    Score: 0.007
  5. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial. Thromb Res. 2017 Mar; 151:89-95.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.